Insider Trading March 9, 2026

Guggenheim Active Allocation Fund Trustee Sells $47,550 in Shares

Barnes Randall C reduces position by 3,000 shares; fund continues to trade below sale price while offering a double-digit yield

By Jordan Park GUG
Guggenheim Active Allocation Fund Trustee Sells $47,550 in Shares
GUG

Trustee Barnes Randall C executed a sale of 3,000 shares of Guggenheim Active Allocation Fund (GUG) on March 6, 2026, for $15.85 per share, netting $47,550. After the trade the trustee retains 62,322 shares. The fund currently trades at $15.58, has a market capitalization of $518.78 million, has returned 10.63% over the last year, and carries a 9.06% dividend yield according to InvestingPro.

Key Points

  • Trustee Barnes Randall C sold 3,000 shares of Guggenheim Active Allocation Fund on March 6, 2026 for $15.85 per share, totaling $47,550.
  • After the sale Barnes directly owns 62,322 shares of the fund.
  • GUG was trading at $15.58, has a market cap of $518.78 million, a 12-month return of 10.63%, and a dividend yield of 9.06% per InvestingPro.

Trustee Barnes Randall C disclosed a sale of 3,000 shares of common stock in Guggenheim Active Allocation Fund (GUG) on March 6, 2026, according to a Form 4 filed with the Securities and Exchange Commission. The reported sales price was $15.85 per share, producing a total transaction value of $47,550.

Following the transaction, the filing shows Barnes holds 62,322 shares of the fund directly. At the time of the report, GUG was trading at $15.58 and carried a market capitalization of $518.78 million. Over the past 12 months the fund has delivered a total return of 10.63%.

InvestingPro reports that the fund currently offers a 9.06% dividend yield and notes that it tracks three additional key tips for GUG investors. The filing did not include an explanation for the sale, and no further commentary from the trustee was disclosed in the SEC submission.

Below is a concise recap of the transaction and the fund metrics disclosed alongside the Form 4 report.

  • Transaction: Sale of 3,000 shares by trustee Barnes Randall C on March 6, 2026.
  • Sale price: $15.85 per share, totaling $47,550.
  • Post-transaction holding: 62,322 shares directly owned by Barnes.
  • Market snapshot: GUG trading at $15.58, market cap $518.78 million, 12-month return 10.63%.
  • Income metric: Reported dividend yield of 9.06% per InvestingPro.

The regulatory filing provides the hard transaction details and the current public metrics for the fund. It does not offer insight into the trustee's motivations or whether the sale reflects a broader strategy.


Readers and market participants evaluating the holding may weigh the disclosed sale alongside the fund's yield and recent return, while noting the limited scope of information available in the Form 4 about rationale or timing beyond the transaction date and price.

Risks

  • The SEC Form 4 filing does not state the trustee's reasons for selling, leaving the motivations and potential future actions unclear - this creates uncertainty for investors assessing insider activity.
  • Market price movement since the sale date is a variable not addressed in the filing; the fund was trading below the sale price at $15.58, which could affect valuation perceptions.
  • The high dividend yield of 9.06% is a notable income feature, but dividend levels and sustainability are not discussed in the disclosure, representing an information gap for income-focused investors.

More from Insider Trading

Spyre Therapeutics CFO Disposes $370K in Stock, Exercises Options Same Day as Trial Timelines Accelerate Apr 3, 2026 Fold Holdings CEO completes modest stock sale to cover RSU tax obligations Apr 3, 2026 Spyre Therapeutics CEO Executes $739,912 Stock Sale as Trials Accelerate Apr 3, 2026 Spyre Therapeutics CMO Sells Shares, Exercises Options as Trials Accelerate Apr 3, 2026 Fold CFO Sells Small Stake to Meet Tax Withholding as Company Faces Revenue Shortfall Apr 3, 2026